Antibacterial, anti-biofilm, and anti-adhesive activities of melittin, a honeybee venom-derived peptide, against quinolone-resistant uropathogenic Escherichia coli (UPEC)

References

• Alder J, Eisenstein B. 2004. The advantage of bactericidal drugs in the treatment of infection. Curr Infect Dis Rep. 6(4):251–253.
   PubMedGoogle Scholar
• Ali I, Rafaque Z, Ahmed S, Malik S, Dasti JI. 2016. Prevalence of multi-drug resistant uropathogenic Escherichia coli in Potohar region of Pakistan. Asian Pac J Trop Biomed. 6(1):60–66.
   Web of Science ®Google Scholar
• Alsafar MA, Obied HN, Ghaleb RA, Kashikol AS. 2020. In-vitro cytotoxic anticancer effects of honeybee venom fractions on different cell lines. Inter J Drug Del Techno (IJDDT). 10(1):141–144.
   Google Scholar
• Bechinger B, Gorr SU. 2017. Antimicrobial peptides: mechanisms of action and resistance. J Dent Res. 96(3):254–260.
   PubMed Web of Science ®Google Scholar
• Chen CH, Lu TK. 2020. Development and challenges of antimicrobial peptides for therapeutic applications. Antibiotics. 9(1):24.
   Google Scholar
• Choi JH, Jang AY, Lin S, Lim S, Kim D, Park K, Han SM, Yeo JH, Seo HS. 2015. Melittin, a honeybee venom‑derived antimicrobial peptide, may target methicillin‑resistant Staphylococcus aureus. Mol Med Rep. 12(5):6483–6490.
   PubMed Web of Science ®Google Scholar
• da Silva RCRM, de Júnior POM, Gonçalves LF, Martins VP, de Melo ABF, Pitondo-Silva A, de Campos TA. 2017. Ciprofloxacin resistance in uropathogenic Escherichia coli isolates causing community-acquired urinary infections in Brasília, Brazil. J Glob Antimicrob Resist. 9:61–67.
   PubMed Web of Science ®Google Scholar
• El-Seedi H, Abd El-Wahed A, Yosri N, Musharraf SG, Chen L, Moustafa M, Zou X, Al-Mousawi S, Guo Z, Khatib A, et al. 2020. Antimicrobial properties of Apis mellifera’s bee venom. Toxins (Basel). 12(7):451.
   PubMed Web of Science ®Google Scholar
• Halaji M, Shahidi S, Atapour A, Ataei B, Feizi A, Havaei SA. 2020. Characterization of extended-spectrum β-lactamase-producing uropathogenic < em>Escherichia coli among Iranian kidney transplant patients. Infect Drug Resist. 13(5):1429–1437.
   PubMedGoogle Scholar
• Han S, Yeo J, Baek H, Lin S-M, Meyer S, Molan P. 2009. Postantibiotic effect of purified melittin from honeybee (Apis mellifera) venom against Escherichia coli and Staphylococcus aureus. J Asian Nat Prod Res. 11(9):796–804.
   PubMed Web of Science ®Google Scholar
• Jacobsen SM, Stickler DJ, Mobley HLT, Shirtliff ME. 2008. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev. 21(1):26–59.
   PubMed Web of Science ®Google Scholar
• Kang SJ, Park SJ, Mishig-Ochir T, Lee BJ. 2014. Antimicrobial peptides: therapeutic potentials. Expert Rev anti Infect Ther. 12(12):1477–1486.
   PubMed Web of Science ®Google Scholar
• Kaper JB, Nataro JP, Mobley HLT. 2004. Pathogenic Escherichia coli. Nat Rev Microbiol. 2(2):123–140.
   PubMed Web of Science ®Google Scholar
• Kucheria R, Dasgupta P, Sacks SH, Khan MS, Sheerin MS. 2005. Urinary tract infections: new insights into a common problem. Postgrad Med J. 81(952):83–86.
   PubMed Web of Science ®Google Scholar
• Leandro LF, Mendes CA, Casemiro LA, Vinholis AHC, Cunha WR, De Almeida R, Martins CHG. 2015. Antimicrobial activity of apitoxin, melittin and phospholipase A2 of honey bee (Apis mellifera) venom against oral pathogens. An Acad Bras Cienc. 87(1):147–155.
   PubMed Web of Science ®Google Scholar
• Lee JH, Subhadra B, Son Y-J, Kim DH, Park HS, Kim JM, Koo SH, Oh MH, Kim H-J, Choi CH. 2016. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea. Lett Appl Microbiol. 62(1):84–90.
   PubMed Web of Science ®Google Scholar
• Lima WG, de Brito JCM, Cardoso VN, Fernandes SOA. 2021. In-depth characterization of antibacterial activity of melittin against Staphylococcus aureus and use in a model of non-surgical MRSA-infected skin wounds. Eur J Pharm Sci. 156:105592.
   PubMed Web of Science ®Google Scholar
• Memariani H, Memariani M, Shahidi-Dadras M, Nasiri S, Akhavan MM, Moravvej H. 2019. Melittin: from honeybees to superbugs. Appl Microbiol Biotechnol. 103(8):3265–3276.
   PubMed Web of Science ®Google Scholar
• Mittal S, Sharma M, Chaudhary U. 2015. Biofilm and multidrug resistance in uropathogenic Escherichia coli. Pathog Glob Health. 109(1):26–29.
   PubMed Web of Science ®Google Scholar
• Mohamed MF, Abdelkhalek A, Seleem MN. 2016. Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus. Sci Rep. 6:29707.
   PubMed Web of Science ®Google Scholar
• Nicolle LE, Evans G, Laverdieve M, Phillips P, Quan C, Rotstein C, AMMI Canada Guidelines Committee. 2005. Complicated urinary tract infection in adults. Can J Infect Dis Med Microbiol. 16(6):349–360.
   PubMedGoogle Scholar
• Pandey BK, Ahmad A, Asthana N, Azmi S, Srivastava RM, Srivastava S, Verma R, Vishwakarma AL, Ghosh JK. 2010. Cell-selective lysis by novel analogues of melittin against human red blood cells and Escherichia coli. Biochemistry. 49(36):7920–7929.
   PubMed Web of Science ®Google Scholar
• Picoli T, Peter CM, Zani JL, Waller SB, Lopes MG, Boesche KN, Vargas GD, Hübner S de O, Fischer G. 2017. Melittin and its potential in the destruction and inhibition of the biofilm formation by Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa isolated from bovine milk. Microb Pathog. 112:57–62.
   PubMed Web of Science ®Google Scholar
• Primon-Barros M, Macedo AJ. 2017. Animal venom peptides: potential for new antimicrobial agents. Curr Top Med Chem. 17(10):1119–1156.
   PubMed Web of Science ®Google Scholar
• Rawat D, Nair D. 2010. Extended-spectrum β-lactamases in Gram negative bacteria. J Glob Infect Dis. 2(3):263–274.
   PubMedGoogle Scholar
• Samy RP, Stiles BG, Franco OL, Sethi G, Lim LHK. 2017. Animal venoms as antimicrobial agents. Biochem Pharmacol. 134:127–138.
   PubMed Web of Science ®Google Scholar
• Son DJ, Lee JW, Lee YH, Song HS, Lee CK, Hong JT. 2007. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther. 115(2):246–270.
   PubMed Web of Science ®Google Scholar
• Stocker JF, Traynor JR. 1986. The action of various venoms on Escherichia coli. J Appl Bacteriol. 61(5):383–388.
   PubMedGoogle Scholar
• Strohalm M, Hassman M, Košata B, Kodíček M. 2008. mMass data miner: an open source alternative for mass spectrometric data analysis. Rapid Commun Mass Spectrom. 22(6):905–908.
   PubMed Web of Science ®Google Scholar
• Tängdén T. 2014. Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria. Ups J Med Sci. 119(2):149–153.
   PubMed Web of Science ®Google Scholar
• Vieira DC, Lima WG, de Paiva MC. 2020. Plasmid-mediated quinolone resistance (PMQR) among Enterobacteriales in Latin America: a systematic review. Mol Biol Rep. 47(2):1471–1483.
   PubMed Web of Science ®Google Scholar
• Vila J, Sáez-López E, Johnson JR, Römling U, Dobrindt U, Cantón R, Giske CG, Naas T, Carattoli A, Martínez-Medina M, et al. 2016. Escherichia coli: an old friend with new tidings. FEMS Microbiol Rev. 40(4):437–463.
   PubMed Web of Science ®Google Scholar
• Warren JW. 1997. Catheter-associated urinary tract infections. Infect Dis Clin North Am. 11(3):609–622.
   PubMed Web of Science ®Google Scholar
• Wu Q, Patočka J, Kuča K. 2018. Insect antimicrobial peptides, a mini review. Toxins (Basel). 10(11):461.
   PubMed Web of Science ®Google Scholar
• Yamamoto S. 2016. Prevention and treatment of complicated urinary tract infection. Urol Sci. 27(4):186–189.
   Google Scholar
• Yasir M, Willcox MDP, Dutta D. 2018. Action of antimicrobial peptides against bacterial biofilms. Materials (Basel). 11(12):2468.
   PubMed Web of Science ®Google Scholar